We provide you with 20 years of free, institutional-grade data for ZNTL stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ZNTL. Explore the full financial landscape of ZNTL stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Myers Scott Dunseth | Grant, award...etc | 57,603 | 2025-06-18 | ||
| Walker Luke Nathaniel | Grant, award...etc | 57,603 | 2025-06-18 | ||
| Johnson David Michael | Grant, award...etc | 57,603 | 2025-06-18 | ||
| Skvarka Jan | Grant, award...etc | 57,603 | 2025-06-18 | ||
| Kariuki Enoch | Grant, award...etc | 57,603 | 2025-06-18 | ||
| Myers Scott Dunseth | Open Market Purchase | 21,000 | $1.4 | 2025-04-30 | |
| Bruns Ingmar | Open Market Purchase | 20,000 | $2.28 | 2025-02-12 | |
| EASTLAND JULIA MARIE | Grant, award...etc | 59,388 | 2025-02-05 | ||
| Vultaggio Vincent | Sale | -2,615 | $1.71 | $4,476 | 2025-02-05 |
| Vultaggio Vincent | Grant, award...etc | 158,586 | 2025-02-05 | ||
| Paul Andrea | Sale | -13,230 | $1.71 | $22,643 | 2025-02-05 |
| Paul Andrea | Grant, award...etc | 934,041 | 2025-02-05 | ||
| Lackner Mark | Sale | -14,368 | $1.71 | $24,591 | 2025-02-05 |
| Lackner Mark | Grant, award...etc | 335,907 | 2025-02-05 | ||
| Bruns Ingmar | Grant, award...etc | 16,629 | 2025-02-05 | ||
| Skvarka Jan | Open Market Purchase | 60,000 | $1.72 | 2025-02-04 | |
| Walker Luke Nathaniel | Open Market Purchase | 14,200 | $1.76 | 2025-02-04 | |
| EASTLAND JULIA MARIE | Open Market Purchase | 28,500 | $1.73 | 2025-02-04 | |
| Lackner Mark | Sale | -4,411 | $3.12 | $13,762 | 2025-01-03 |
| Myers Scott Dunseth | Grant, award...etc | 260,192 | 2024-11-13 | ||
| Vultaggio Vincent | Sale | -1,603 | $3.18 | $5,098 | 2024-10-04 |
| Skvarka Jan | Grant, award...etc | 41,581 | 2024-06-21 | ||
| Johnson David Michael | Grant, award...etc | 48,429 | 2024-06-21 | ||
| Kariuki Enoch | Grant, award...etc | 41,581 | 2024-06-21 | ||
| Gallagher Cam | Sale | -9,597 | $11.98 | $114,972 | 2024-05-31 |
| Walker Luke Nathaniel | Grant, award...etc | 72,481 | 2024-05-29 | ||
| HAUSMAN DIANA | Sale | -3,356 | $12.62 | $42,353 | 2024-05-09 |
| Vultaggio Vincent | Initial | 2024-04-11 | |||
| Epperly Melissa B, | Sale | -2,573 | $11.44 | $29,435 | 2024-02-12 |
| Gallagher Cam | Sale | -1,173 | $11.44 | $13,419 | 2024-02-12 |
| Blackwell Kimberly | Sale | -20,655 | $11.69 | $241,457 | 2024-02-05 |
| Blackwell Kimberly | Grant, award...etc | 250,000 | 2024-02-05 | ||
| Epperly Melissa B, | Sale | -8,669 | $11.54 | $100,040 | 2024-02-05 |
| Epperly Melissa B, | Grant, award...etc | 75,000 | 2024-02-05 | ||
| HAUSMAN DIANA | Grant, award...etc | 337,500 | 2024-02-05 | ||
| Paul Andrea | Sale | -3,310 | $11.54 | $38,197 | 2024-02-05 |
| Paul Andrea | Grant, award...etc | 112,500 | 2024-02-05 | ||
| Lackner Mark | Sale | -1,585 | $11.54 | $18,291 | 2024-02-05 |
| Lackner Mark | Grant, award...etc | 141,000 | 2024-02-05 | ||
| Gallagher Cam | Sale | -11,552 | $11.54 | $133,310 | 2024-02-05 |
| Gallagher Cam | Grant, award...etc | 192,500 | 2024-02-05 | ||
| Lackner Mark | Initial | 2024-01-03 | |||
| Lackner Mark | Grant, award...etc | 40,000 | 2024-01-03 | ||
| Johnson David Michael | Open Market Purchase | 17,000 | $9.88 | 2023-11-13 | |
| Blackwell Kimberly | Open Market Purchase | 5,000 | $10.29 | 2023-11-13 | |
| Brownstein Carrie | Sale | -10,628 | $19.43 | $206,465 | 2023-10-06 |
| Epperly Melissa B, | Sale | -5,482 | $19.43 | $106,496 | 2023-10-06 |
| Bunker Kevin D. | Sale | -6,068 | $19.43 | $117,880 | 2023-10-06 |
| Skvarka Jan | Sale | -5,000 | $25.05 | $125,238 | 2023-09-13 |
| Matrix Capital Management Company, LP | Open Market Purchase | 4,760,000 | $22.66 | 2023-06-20 | |
| Johnson David Michael | Grant, award...etc | 19,059 | 2023-06-16 | ||
| Kariuki Enoch | Grant, award...etc | 16,364 | 2023-06-16 | ||
| Skvarka Jan | Grant, award...etc | 16,364 | 2023-06-16 | ||
| Gallagher Cam | Sale | -27,768 | $26.4 | $733,045 | 2023-05-31 |
| Bunker Kevin D. | Sale | -80,000 | $30.02 | $2,401,248 | 2023-05-31 |
| HAUSMAN DIANA | Grant, award...etc | 39,732 | 2023-05-10 | ||
| Roth Iris | Grant, award...etc | 52,500 | 2023-03-02 | ||
| Epperly Melissa B, | Sale | -7,851 | $20.42 | $160,352 | 2023-02-14 |
| Gallagher Cam | Sale | -11,833 | $20.42 | $241,682 | 2023-02-14 |
| Bunker Kevin D. | Sale | -10,307 | $20.42 | $210,514 | 2023-02-14 |
The information provided in this report about ZNTL stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Zentalis Pharmaceuticals, Inc(NASDAQ:ZNTL) 
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidates are the ZN-c5, an oral selective estrogen receptor degrader that is in a Phase 1/2 clinical ...
Website: http://www.zentalis.com
Full Time Employees: 110
CEO: Anthony Y. Sun
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends